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A New Naphthalene Preparation in the  
Management of Psoriasis
 Naphthalene AA-Final, a naphthalene prepara-
tion, is a new tool in the management of psoria-
sis. 
 Brown naphthalene has been used for 15 years 
in the treatment of psoriasis at Special Hospital 
for Medical Rehabilitation in Ivanic Grad, Croatia. 
Naphthalene is obtained from naphtha, a complex 
mixture of various compounds, mostly hydrocar-
bons. Naphthalene AA-Final is a new naphthalene 
preparation enriched with sterans, constituents 
believed to represent active naphthalene com-
ponents, while the content of polyaromatics has 
been substantially reduced. Experimental model 
studies revealed no genotoxicity. The preparation 
is available in the form of oil. A pilot study including 
11 patients with psoriasis vulgaris was performed 
at Naftalan Special Hospital to assess the clinical 
efficacy of Naphthalene AA-Final. Upon obtain-
ing an informed consent in writing from all study 
patients, Naphthalene AA-Final was applied over 
involved skin areas once daily for three weeks. 
PASI score was recorded before (22.4) and after 
(7.85) treatment. The new preparation tolerabil-
ity was good and free from side effects or altera-
tions in hematology and biochemistry parame-
ters. The new preparation Naphthalene AA-Final 
proved to be an efficacious and well tolerated lo-
cal agent for use in rotation therapy of psoriasis. 
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 Results obtained by the application of Naph-
thalene AA-Final will be presented in detail at the 
2nd Croatian-Italian Symposium on Psoriasis to be 
held at Naftalan Special Hospital on September 
23-24, 2005. Other current, very interesting thera-
peutic approaches in psoriasis as well as biologi-
cals, methotrexate, tazarotene, UVB, PUVA, and 
narrow-band UVB microphototherapy will also be 
presented. The following topics will be discussed: 
Living with psoriasis; Clinical and immunogenetic 
profile of guttate psoriasis; Apoptotic mechanisms 
in psoriasis; Proliferation in psoriasis; Collagen 
binding receptors in psoriasis; The role of adhe-
sion molecules in psoriasis; Some news in pho-
tobiology; Contact allergy in psoriasis; Psoriasis 
vulgaris and coexisting diseases; Psychological 
characteristics of psoriatic patients; Psoriasis and 
HIV – what’s new?; and Video-capillaroscopy as a 
diagnostic tool in psoriasis.  
 The rich scientific program will provide due 
information on the new aspects in psoriasis. Let 
us all enjoy in the scientific program and social 
events!
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